Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy

American Journal of Gastroenterology

Volumn 93, Issue 2, 1998, Pages 223-226

  Marzio, Leonardo ^a,b   Angelucci, Domenico ^a   Grossi, Laurino ^a   Diodoro, Maria Grazia ^a   Di Campli, Emanuela ^a   Cellini, Luigina ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Scuola di Gastroenterologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; METRONIDAZOLE; OMEPRAZOLE; POLYCLONAL ANTIBODY; UREASE;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOID TISSUE; MALE; PRIORITY JOURNAL; STOMACH BIOPSY; STOMACH MUCOSA;

ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; ANTIBODIES, BACTERIAL; BIOPSY; DRUG THERAPY, COMBINATION; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; PYLORIC ANTRUM;

EID: 0032008430     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00223.x     Document Type: Article

References (27)

1. 1. Rauws EA, Langerberg W, Houthoff HJ, et al. Campylobacter pyloridis-associated chronic active antral gastritis. Gastroenterology 1988; 94:33-40.
2. 2. Lambert JR, Lin SK, Aranda-Michel J. Helicobacter pylori. Scand J Gastroenterol 1995;30(suppl 208):33-46.
3. 3. Hu PJ, Li JJ, Lin HL, et al. Gastric atrophy and regional variation in upper gastrointestinal disease. Am J Gastroenterol 1995;90:1102-6.
4. 4. Dick JD. Helicobacter (Campylobacter) pylori: A twist on an old disease. Ann Rev Microbiol 1990;108:70-90
5. 5. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. New Engl J Med 1991; 325:1127-31.
6. 6. Ortiz-Hidalgo C, Falzan MR, Isacson PG. Helicobacter pylori associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338: 1175-6.
7. 7. Cellini L, Allocati N, Angelucci D, et al. Coccoid Helicobacter pylori not culturable in vitro reverts in mice. Microbiol Immunol 1994;38:843-50.
8. 8. Gribbon LT, Barer MR. Oxidative metabolism in nonculturable Helicobacter pylori and Vibrio vulnificus in cells studied by substrate-enhanced tetrazolium reduction and digital image processing. Appl Envir Microbiol 1995;61:3379-84.
9. 9. Jones DM, Curry A. The genesis of coccal forms of Helicobacter pylori. In: Malfertheiner P, Ditschuneit H, eds. Helicobacter pylori, gastritis and peptic ulcer. Berlin: Springer Verlag; 1990:29-37.
10. 10. Cellini L, Allocati N, Di Campli E, et al. Helicobacter pylori: A fickle germ. Microbiol Immunol 1994;38:25-30.
11. 11. Chan WY, Hui PK, Leung KM, et al. Coccoid forms of Helicobacter pylori in the human stomach. Am J Clin Pathol 1994;102:503-7.
12. 12. Xia HX, Gilvarry J, Beattie S, et al. Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens. Am J Gastroenterol 1995;90:1221-5.
13. 13. Elta GH. Helicobacter pylori reinfection: What's the risk? Gastroenterology 1994;107:1563-4.
14. 14. Cellini L, Allocati N, Piccolomini R, et al. New plate medium for growth and detection of urease activity of Helicobacter pylori. J Clin Microbiol 1992;30:1351-3.
15. 15. Hazell SL. Cultural techniques for the growth and isolation of Helicobacter pylori. In: Goodwin CS, Worsley BW, eds. Helicobacter pylori: Biology and clinical practice. Boca Raton, FL: CRC Press, 1993:273-83.
16. 16. Price AB. The Sydney system: Histological division. J Gastroenterol Hepatol 1991;6:209-22.
17. 17. Andersen LP, Holck S, Poulsen CO. Campylobacter pylori detected by indirect immunohistochemical technique. APMIS 1988;95:559-64.
18. 18. Ashton-Key M, Diss TC, Jsaacson PG. Detection of Helicobacter pylori in gastric biopsy and resection specimens. J Clin Pathol 1996;49:107-11.
19. 19. Andersen LP, Raskov H, Elsborg L, et al. Prevalence of antibodies against heat-stable antigens from Helicobacter pylori in patients with dyspeptic symptoms and normal persons. APMIS 1992;100:779-89.
20. 20. Chan W-Y, Hui P-K, Leung K-M, et al. Coccoid forms of Helicobacter pylori in the human stomach. Am J Clin Pathol 1994;102:503-7.
21. 21. De Boer WA, Tytgat GNJ. The best therapy for Helicobacter pylori infection: Should efficacy or side-effect profile determine our choice? Scand J Gastroenterol 1995;30:401-7.
22. 22. Burette A, Glupczynsky Y. Helicobacter pylori: The place of the new macrolides in the eradication of the bacteria in peptic ulcer disease. Infection 1995;S44-S52.
23. 23. Fraser AG, Bikley J, Owen RJ, et al. DNA fingerprints of Helicobacter pylori before and after treatment with omeprazole. J Clin Pathol 1992;45:1062-5.
24. 24. Xia XH, Windle HJ, Marshall DG, et al. Recrudescence of Helicobacter pylori after apparently successful eradication: Novel application of randomly amplified polymorphic DNA fingerprinting. Gut 1995;37:30-34.
25. 25. Cammarota G, Tursi A, Montalto M, et al. Prevention and treatment of low-grade B-cell primary gastric lymphoma by anti-H. pylori therapy. J Clin Gastroenterol 1995;21:118-22.
26. 26. Bayerdorffer E, Neubauer A, Burkhard R, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet 1995;345:1591-4.
27. 27. Roggero E, Zucca E, Pinotti G, et al. Eradication of Helicobacter pylori infection in primary low grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995;122:767-9.